The success of gene therapy mainly depends on the carriers for effective gene delivery. A non-viral vector using a cationic block co-polyelectrolyte, PEI-PLA-PEG polyethyleneimine-poly(lactic acid)-poly(ethylene glycol)) was developed as a potential gene carrier. The cationic PEI-PLA-PEG showed less toxicity compared to PEI and formed a gene nanocomplex (termed polyplex) by interaction with plasmid DNA or small interference RNA. The polyplex showed smaller particle size and greater positive zeta potential by increasing the high polymer nitrogen/DNA phosphate ratio. The polyplex with a nitrogen/DNA phosphate ratio of 16 or 32 demonstrated higher gene transfection by fluorescence imaging, flow cytometry measurement, and β-galactosidase activity. In particular, the polyplex with therapeutic histone deacetylase small interference RNA at nitrogen/DNA phosphate ratio 16 showed the most favorable properties with definite tumor growth inhibition. The synthetic PEI-PLA-PEG also showed less toxicity and would, therefore, be a great potential gene carrier, particularly given that small interference RNA delivery does not increase the charge density of small interference RNA due to the formation of a stable complex through conjugation with PLA-PEG.
LiuYNguyenJSteeleT. A new synthesis method and degradation of hyper-branched polyethylenimine grafted polycaprolactone block mono-methoxyl poly (ethylene glycol) copolymers (hy-PEI-g-PCL-b-mPEG) as potential DNA delivery vectors. Polymer2009; 50: 3895–3904.
5.
PichonCBillietLMidouxP. Chemical vectors for gene delivery: uptake and intracellular trafficking. Curr Opin Biotech2010; 21: 640–645.
6.
AhnCHChaeSYBaeYH. Biodegradable poly(ethylenimine) for plasmid DNA delivery. J Control Release2002; 80: 273–282.
7.
YinDChuCDingX. Nonionic amphiphilic surfactant conjuncted polyethyleneimine as a new and highly efficient non-viral fene carrier. Macromol Res2009; 17: 19–25.
ParveenSSahooSK. Polymeric nanoparticles for cancer therapy. J Drug Target2008; 16: 108–123.
10.
PengLGaoYXueY-N. The effectiveness, cytotoxicity, and intracellular trafficking of nonviral vectors for gene delivery to bone mesenchymal stem cells. J Bioact Compat Pol2013; 28: 204–217.
11.
BaumhoverNJDuskeyJTKharghariaS. Structure-activity relationship of PEGylated polylysine peptides as scavenger receptor inhibitors for non-viral gene delivery. Mol Pharm2015; 12: 4321–4328.
12.
KanoAMoriyamaKYamanoT. Grafting of poly(ethylene glycol) to poly-lysine augments its lifetime in blood circulation and accumulation in tumors without loss of the ability to associate with siRNA. J Control Release2011; 149: 2–7.
13.
KodamaYNakamuraTKurosakiT. Biodegradable nanoparticles composed of dendrigraft poly-l-lysine for gene delivery. Eur J Pharm Biopharm2014; 87: 472–479.
14.
MannistoMVanderkerkenSTonchevaV. Structure-activity relationships of poly(L-lysines): effects of PEGylation and molecular shape on physicochemical and biological properties in gene delivery. J Control Release2002; 83: 169–182.
15.
MaoSSunWKisselT. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev2010; 62: 12–27.
16.
WangJFengS-SWangS. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment. Int J Pharm2010; 400: 194–200.
17.
KimJ-SKimB-IMaruyamaA. A new non-viral DNA delivery vector: the terplex system. J Control Release1998; 53: 175–182.
18.
LiJLiSXiaS. Enhanced transfection efficiency and targeted delivery of self-assembling h-R3-dendriplexes in EGFR-overexpressing tumor cells. Oncotarget2015; 6: 26177–26191.
19.
ChenC-KJonesCHMistriotisP. Poly(ethylene glycol)-block-cationic polylactide nanocomplexes of differing charge density for gene delivery. Biomaterials2013; 34: 9688–9699.
20.
SinghBMaharjanSParkTE. Tuning the buffering capacity of polyethylenimine with glycerol molecules for efficient gene delivery: staying in or out of the endosomes. Macromol Biosci2015; 15: 622–635.
21.
KlemmARYoungDLloydJB. Effects of polyethyleneimine on endocytosis and lysosome stability. Biochem Pharmacol1998; 56: 41–46.
22.
NeuMFischerDKisselT. Recent advances in rational gene transfer vector des0069gn based on poly(ethylene imine) and its derivatives. J Gene Med2005; 7: 992–1009.
23.
LeeMRentzJHanSO. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Ther2003; 10: 585–593.
24.
FischerDBieberTLiY. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res1999; 16: 1273–1279.
25.
WangCHHsiueGH. Polymer-DNA hybrid nanoparticles based on folate-polyethylenimine-block-poly(L-lactide). Bioconjug Chem2005; 16: 391–396.
26.
DengRYueYJinF. Revisit the complexation of PEI and DNA—how to make low cytotoxic and highly efficient PEI gene transfection non-viral vectors with a controllable chain length and structure?J Control Release2009; 140: 40–46.
27.
KircheisRWightmanLWagnerE. Design and gene delivery activity of modified polyethylenimines. Adv Drug Deliv Rev2001; 53: 341–358.
28.
TangGPZengJMGaoSJ. Polyethylene glycol modified polyethylenimine for improved CNS gene transfer: effects of PEGylation extent. Biomaterials2003; 24: 2351–2362.
29.
PetersenHFechnerPMMartinAL. Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem2002; 13: 845–854.
30.
LeeSJSonSYheeJY. Structural modification of siRNA for efficient gene silencing. Biotechnol Adv2013; 31: 491–503.
31.
MokHLeeSHParkJW. Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. Nat Mater2010; 9: 272–278.
32.
HattoriYMaitaniY. Low-Molecular-Weight Polyethylenimine Enhanced Gene Transfer by Cationic Cholesterol-Based Nanoparticle Vector. Biol Pharm Bull2007; 30: 1773–1778.
33.
OhKTBronichTKBrombergL. Block ionomer complexes as prospective nanocontainers for drug delivery. J Control Release2006; 115: 9–17.
34.
ShuaiXMerdanTUngerF. Novel biodegradable ternary copolymers hy-PEI-g-PCL-b-PEG: synthesis, characterization, and potential as efficient nonviral gene delivery vectors. Macromolecules2003; 36: 5751–5759.
35.
SunTMDuJZYanLF. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery. Biomaterials2008; 29: 4348–4355.
36.
KamimuraMKimJOKabanovAV. Block ionomer complexes of PEG-block-poly(4-vinylbenzylphosphonate) and cationic surfactants as highly stable, pH responsive drug delivery system. J Control Release2012; 160: 486–494.
37.
LimCYounYSLeeKS. Development of a robust pH-sensitive polyelectrolyte ionomer complex for anticancer nanocarriers. Int J Nanomedicine2016; 11: 703–713.
38.
LeclercqLBousttaMVertM. Roles of hydrophobicity and charge density on the dynamics of polyelectrolyte complex formation and stability under modeled physicochemical blood conditions. J Bioact Compat Pol2012; 27: 161–173.
39.
KunathKvon HarpeAPetersenH. The structure of PEG-modified poly(ethylene imines) influences biodistribution and pharmacokinetics of their complexes with NF-κB decoy in mice. Pharm Res2002; 19: 810–817.
40.
MerdanTKunathKPetersenH. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice. Bioconjug Chem2005; 16: 785–792.
41.
LiuYSteeleTKisselT. Degradation of hyper-branched poly(ethylenimine)-graft-poly(caprolactone)-block-monomethoxyl-poly(ethylene glycol) as a potential gene delivery vector. Macromol Rapid Commun2010; 31: 1509–1515.
42.
TangMXRedemannCTSzokaFC. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem1996; 7: 703–714.
43.
XuPQuickGKYeoY. Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine. Biomaterials2009; 30: 5834–5843.
44.
HealdCRStolnikSKujawinskiKS. Poly(lactic acid)−Poly(ethylene oxide) (PLA−PEG) nanoparticles: NMR studies of the central solidlike PLA core and the liquid PEG corona. Langmuir2002; 18: 3669–3675.
45.
HanS-oMahatoRIKimSW. Water-soluble lipopolymer for gene delivery. Bioconjug Chem2001; 12: 337–345.
46.
ParkY-MShinB-AOhI-J. Poly(L-lactic acid)/polyethylenimine nanoparticles as plasmid DNA carriers. Arch Pharm Res2008; 31: 96–102.
47.
FengLZhangSLiuZ. Graphene based gene transfection. Nanoscale2011; 3: 1252–1257.
48.
ZhangXPanSRHuHM. Poly(ethylene glycol)-block-polyethylenimine copolymers as carriers for gene delivery: effects of PEG molecular weight and PEGylation degree. J Biomed Mater Res A2008; 84: 795–804.
49.
EndresTKBeck-BroichsitterMSamsonovaO. Self-assembled biodegradable amphiphilic PEG-PCL-lPEI triblock copolymers at the borderline between micelles and nanoparticles designed for drug and gene delivery. Biomaterials2011; 32: 7721–7731.
50.
Rezvani AminZRahimizadehMEshghiH. The effect of cationic charge density change on transfection efficiency of polyethylenimine. Iran J Basic Med Sci2013; 16: 150–156.
51.
KleideiterGNordmeierE. Poly(ethylene glycol)-induced DNA condensation in aqueous/methanol containing low-molecular-weight electrolyte solutions: theoretical considerations. Polymer1999; 40: 4013–4023.
52.
PanyamJLabhasetwarV. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev2003; 55: 329–347.
53.
Yin WinKFengS-S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials2005; 26: 2713–2722.
54.
GuyJDrabekDAntoniouM. Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy. Mol Biotechnol1995; 3: 237–248.
55.
MokHParkTG. Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA. Biopolymers2008; 89: 881–888.
56.
El-SayedAHarashimaH. Endocytosis of gene delivery vectors: from clathrin-dependent to Lipid Raft-mediated endocytosis. Mol Ther2013; 21: 1118–1130.
57.
HayashiAHoriuchiAKikuchiN. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: hDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin. Int J Cancer2010; 127: 1332–1346.
58.
GlaserKBLiJStaverMJ. Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA. Biochem Biophys Res Commun2003; 310: 529–536.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
